InChI=1S/C44H79NO9/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-27-30-39(48)45-36(40(49)37(47)32-31-35-28-25-24-26-29-35)34-53-44-43(52)42(51)41(50)38(33-46)54-44/h24-26,28-29,36-38,40-44,46-47,49-52H,2-23,27,30-34H2,1H3,(H,45,48)/t36-,37+,38+,40-,41-,42-,43+,44-/m0/s1 |
XMIBGPITGPVDLO-UHTOCBDZSA-N |
[C@H]1([C@@H]([C@H]([C@H]([C@H](O1)CO)O)O)O)OC[C@@H]([C@@H]([C@@H](CCC=2C=CC=CC2)O)O)NC(CCCCCCCCCCCCCCCCCCCCCCCCC)=O |
|
Outgoing
|
N-[(2S,3S,4R)-1-(α-D-galactosyloxy)-3,4-dihydroxy-6-phenylhexan-2-yl]hexacosanamide
(CHEBI:139219)
has functional parent
α-D-galactose
(CHEBI:28061)
N-[(2S,3S,4R)-1-(α-D-galactosyloxy)-3,4-dihydroxy-6-phenylhexan-2-yl]hexacosanamide
(CHEBI:139219)
is a
α-galactosylceramide
(CHEBI:132148)
|
|
2,5,6-trideoxy-1-O-α-D-galactopyranosyl-2-(hexacosanoylamino)-6-phenyl-D-ribo-hexitol
|
N-[(2S,3S,4R)-1-(α-D-galactopyranosyloxy)-3,4-dihydroxy-6-phenylhexan-2-yl]hexacosanamide
|
IUPAC
|
18641314
|
Reaxys Registry Number
|
Reaxys
|
20616071
|
PubMed citation
|
Europe PMC
|
|